Cue Biopharma, Inc. (CUE)
Nasdaq: CUE · CIK 0001645460 · United States
Every official Cue Biopharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CUE filings
Cue Biopharma, Inc. documents
- Cue Biopharma, Inc. 10-K 2026CUE 10-K 2026: annual report for fiscal 2026
- Cue Biopharma, Inc. 10-K 2025CUE 10-K 2025: annual report for fiscal 2025
- Cue Biopharma, Inc. 10-K 2024CUE 10-K 2024: annual report for fiscal 2024
- Cue Biopharma, Inc. 10-K 2023CUE 10-K 2023: annual report for fiscal 2023
- Cue Biopharma, Inc. 10-K 2022CUE 10-K 2022: annual report for fiscal 2022
- Cue Biopharma, Inc. 10-Q 2026CUE 10-Q 2026: quarterly report for fiscal 2026
- Cue Biopharma, Inc. 10-Q 2025CUE 10-Q 2025: quarterly report for fiscal 2025
- Cue Biopharma, Inc. 10-Q 2024CUE 10-Q 2024: quarterly report for fiscal 2024
- Cue Biopharma, Inc. 10-Q 2023CUE 10-Q 2023: quarterly report for fiscal 2023
- Cue Biopharma, Inc. 10-Q 2022CUE 10-Q 2022: quarterly report for fiscal 2022
- Cue Biopharma, Inc. 8-K 2026CUE 8-K 2026: current report for fiscal 2026
- Cue Biopharma, Inc. 8-K 2025CUE 8-K 2025: current report for fiscal 2025
- Cue Biopharma, Inc. 8-K 2024CUE 8-K 2024: current report for fiscal 2024
- Cue Biopharma, Inc. 8-K 2023CUE 8-K 2023: current report for fiscal 2023
- Cue Biopharma, Inc. 8-K 2022CUE 8-K 2022: current report for fiscal 2022
- Cue Biopharma, Inc. DEF 14A 2026CUE DEF 14A 2026: proxy statement for fiscal 2026
- Cue Biopharma, Inc. DEF 14A 2025CUE DEF 14A 2025: proxy statement for fiscal 2025
- Cue Biopharma, Inc. DEF 14A 2024CUE DEF 14A 2024: proxy statement for fiscal 2024
- Cue Biopharma, Inc. DEF 14A 2023CUE DEF 14A 2023: proxy statement for fiscal 2023
- Cue Biopharma, Inc. DEF 14A 2022CUE DEF 14A 2022: proxy statement for fiscal 2022
- Cue Biopharma, Inc. Form 4 2026CUE Form 4 2026: insider trading filing for fiscal 2026
- Cue Biopharma, Inc. Form 4 2025CUE Form 4 2025: insider trading filing for fiscal 2025
- Cue Biopharma, Inc. Form 4 2024CUE Form 4 2024: insider trading filing for fiscal 2024
- Cue Biopharma, Inc. Form 4 2023CUE Form 4 2023: insider trading filing for fiscal 2023
- Cue Biopharma, Inc. Form 4 2022CUE Form 4 2022: insider trading filing for fiscal 2022
- Cue Biopharma, Inc. S-1 2026CUE S-1 2026: registration statement for fiscal 2026
- Cue Biopharma, Inc. S-1 2025CUE S-1 2025: registration statement for fiscal 2025
- Cue Biopharma, Inc. S-1 2024CUE S-1 2024: registration statement for fiscal 2024
- Cue Biopharma, Inc. S-1 2023CUE S-1 2023: registration statement for fiscal 2023
- Cue Biopharma, Inc. S-1 2022CUE S-1 2022: registration statement for fiscal 2022
- Cue Biopharma, Inc. 13F 2026CUE 13F 2026: institutional holdings for fiscal 2026
- Cue Biopharma, Inc. 13F 2025CUE 13F 2025: institutional holdings for fiscal 2025
- Cue Biopharma, Inc. 13F 2024CUE 13F 2024: institutional holdings for fiscal 2024
- Cue Biopharma, Inc. 13F 2023CUE 13F 2023: institutional holdings for fiscal 2023
- Cue Biopharma, Inc. 13F 2022CUE 13F 2022: institutional holdings for fiscal 2022
More companies